Phytoestrogens and inhibition of angiogenesis

被引:104
作者
Fotsis, T [1 ]
Pepper, MS
Montesano, R
Aktas, E
Brett, S
Schweigerer, L
Rasku, S
Wähälä, K
Adlercreutz, M
机构
[1] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece
[2] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva, Switzerland
[3] Univ Essen Gesamthsch, Childrens Hosp, Dept Haematol Oncol & Endocrinol, Essen, Germany
[4] Univ Helsinki, Dept Chem, Organ Chem Lab, SF-00100 Helsinki, Finland
[5] Univ Helsinki, Dept Clin Chem, Folkhalsan Res Ctr, Inst Prevent Med Nutr & Canc, FIN-00014 Helsinki, Finland
来源
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM | 1998年 / 12卷 / 04期
关键词
isoflavonoids; genistein; flavonoids; diet; inhibition; angiogenesis; proliferation;
D O I
10.1016/S0950-351X(98)80009-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The consumption of a plant-based diet can prevent the development and progression of chronic diseases associated with extensive neovascularization, including the progression and growth of solid malignant tumours. We have previously shown that the plant-derived isoflavonoid genistein is a potent inhibitor of cell proliferation and in vitro angiogenesis. Moreover, the concentration of genistein in the urine of subjects consuming a plant-based diet is 30-fold higher than that in subjects consuming a traditional Western diet. We have also reported that certain structurally related flavonoids are more potent inhibitors than genistein. Indeed, 3-hydroxyflavone, 3',4'-dihydroxyflavone, 2',3'-dihydroxyflavone, fisetin, apigenin and luteolin inhibit the proliferation of normal and tumour cells as well as in vitro angiogenesis at half-maximal concentrations in the lower micromolar range. The wide distribution of isoflavonoids and flavonoids in the plant kingdom, together with their anti-angiogenic and anti-mitotic properties, suggest that these phytoestrogens may contribute to the preventive effect of a plant-based diet on chronic diseases, including solid tumours.
引用
收藏
页码:649 / 666
页数:18
相关论文
共 57 条
[1]   LIGNAN AND ISOFLAVONOID CONJUGATES IN HUMAN URINE [J].
ADLERCREUTZ, H ;
VANDERWILDT, J ;
KINZEL, J ;
ATTALLA, H ;
WAHALA, K ;
MAKELA, T ;
HASE, T ;
FOTSIS, T .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 52 (01) :97-103
[3]   URINARY-EXCRETION OF LIGNANS AND ISOFLAVONOID PHYTOESTROGENS IN JAPANESE MEN AND WOMEN CONSUMING A TRADITIONAL JAPANESE DIET [J].
ADLERCREUTZ, H ;
HONJO, H ;
HIGASHI, A ;
FOTSIS, T ;
HAMALAINEN, E ;
HASEGAWA, T ;
OKADA, H .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 54 (06) :1093-1100
[4]   ISOTOPE-DILUTION GAS-CHROMATOGRAPHIC MASS-SPECTROMETRIC METHOD FOR THE DETERMINATION OF LIGNANS AND ISOFLAVONOIDS IN HUMAN URINE, INCLUDING IDENTIFICATION OF GENISTEIN [J].
ADLERCREUTZ, H ;
FOTSIS, T ;
BANNWART, C ;
WAHALA, K ;
BRUNOW, G ;
HASE, T .
CLINICA CHIMICA ACTA, 1991, 199 (03) :263-278
[5]  
AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
[6]   Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I [J].
Boege, F ;
Straub, T ;
Kehr, A ;
Boesenberg, C ;
Christiansen, K ;
Andersen, A ;
Jakob, F ;
Kohrle, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2262-2270
[7]  
Carlson BA, 1996, CANCER RES, V56, P2973
[8]   A NEW CLASS OF STEROIDS INHIBITS ANGIOGENESIS IN THE PRESENCE OF HEPARIN OR A HEPARIN FRAGMENT [J].
CRUM, R ;
SZABO, S ;
FOLKMAN, J .
SCIENCE, 1985, 230 (4732) :1375-1378
[9]  
CUNNINGHAM BDM, 1992, ANTI-CANCER DRUG DES, V7, P365
[10]  
DAS A, 1995, PROGR DRUG RES, P133